Reflects Information That Constitutes a Substantive Change From or Addition to the Information Set Forth in the Last Offering Circular (253g2)
May 04 2022 - 9:08AM
Edgar (US Regulatory)
Filed pursuant to Rule 253(g)(2)
File No. 024-11795
SUPPLEMENT NO 1. DATED MAY 4, 2022
TO THE
OFFERING CIRCULAR DATED FEBRUARY 25, 2022
OF
ITEM 9 LABS CORP
This document supplements, and should be read in conjunction
with, the Offering Circular (the “Offering Circular”) dated February 25, 2022 of Item 9 Labs Corp (the “Company”).
Unless otherwise defined in this supplement, capitalized terms used in this supplement shall have the same meanings as set forth in the
Offering Circular. The purpose of this supplement is to disclose that there is a change in price of the units, change in exercise price
of the warrant, and a change in the minimum investment amount for investors seeking to purchase Units (Common Stock and a half warrant)
of the Company.
Price
Effective immediately, we have modified the price for each unit to $1.12.
All units subscribed prior to the date of this supplement will be retroactively issued the additional units. The information in the Offering
Circular, including “Dilution,” and “Use of Proceeds to Issuer,” is qualified by reference to the new price.
Exercise Price of Warrant
Effective immediately, we have modified the exercise price for each warrant
to $1.75. All units subscribed prior to the date of this supplement will be retroactively issued the additional units. The information
in the Offering Circular, including “Dilution,” and “Use of Proceeds to Issuer,” is qualified by reference to
the new price.
Minimum Investment Amount
The minimum investment amount for investors in the
offering is $560 or 500 units at the price per share of $1.12.
Item 9 Labs (CE) (USOTC:INLB)
Historical Stock Chart
From May 2024 to Jun 2024
Item 9 Labs (CE) (USOTC:INLB)
Historical Stock Chart
From Jun 2023 to Jun 2024
